{"result": "(\"entity\"<|>MUNCK A<|>PERSON<|>Munck A is an author involved in a multicentre study on DIOS and constipation in cystic fibrosis.)\n##\n(\"entity\"<|>HAUSER B<|>PERSON<|>Hauser B is an author contributing to the study on DIOS and constipation in cystic fibrosis.)\n##\n(\"entity\"<|>WALKOWIAK J<|>PERSON<|>Walkowiak J is an author participating in the multicentre study on DIOS and constipation in cystic fibrosis.)\n##\n(\"entity\"<|>DIOS<|>EVENT<|>DIOS (Distal Intestinal Obstruction Syndrome) is a condition being studied in relation to cystic fibrosis.)\n##\n(\"entity\"<|>CYSTIC FIBROSIS<|>EVENT<|>Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, and is the focus of the study.)\n##\n(\"entity\"<|>J PEDIATR GASTROENTEROL NUTR<|>ORGANIZATION<|>Journal of Pediatric Gastroenterology and Nutrition publishes research related to pediatric gastroenterology, including studies on cystic fibrosis.)\n##\n(\"entity\"<|>J CYST FIBROS<|>ORGANIZATION<|>Journal of Cystic Fibrosis publishes research specifically focused on cystic fibrosis and related conditions.)\n##\n(\"relationship\"<|>MUNCK A<|>DIOS<|>Munck A is involved in the study that defines DIOS in cystic fibrosis<|>7)\n##\n(\"relationship\"<|>HAUSER B<|>DIOS<|>Hauser B is involved in the study that defines DIOS in cystic fibrosis<|>7)\n##\n(\"relationship\"<|>WALKOWIAK J<|>DIOS<|>Walkowiak J is involved in the study that defines DIOS in cystic fibrosis<|>7)\n##\n(\"relationship\"<|>DIOS<|>CYSTIC FIBROSIS<|>DIOS is a condition that occurs in patients with cystic fibrosis<|>8)\n##\n(\"relationship\"<|>MUNCK A<|>J PEDIATR GASTROENTEROL NUTR<|>Munck A's research is published in the Journal of Pediatric Gastroenterology and Nutrition<|>6)\n##\n(\"relationship\"<|>HAUSER B<|>J PEDIATR GASTROENTEROL NUTR<|>Hauser B's research is published in the Journal of Pediatric Gastroenterology and Nutrition<|>6)\n##\n(\"relationship\"<|>WALKOWIAK J<|>J PEDIATR GASTROENTEROL NUTR<|>Walkowiak J's research is published in the Journal of Pediatric Gastroenterology and Nutrition<|>6)\n##\n(\"relationship\"<|>MUNCK A<|>J CYST FIBROS<|>Munck A's research is published in the Journal of Cystic Fibrosis<|>6)\n##\n(\"relationship\"<|>HAUSER B<|>J CYST FIBROS<|>Hauser B's research is published in the Journal of Cystic Fibrosis<|>6)\n##\n(\"relationship\"<|>WALKOWIAK J<|>J CYST FIBROS<|>Walkowiak J's research is published in the Journal of Cystic Fibrosis<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: I, Munck A, Hauser B, Walkowiak J, et al. Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 2010; 50:38–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19525866.\n\n25. Dodge JA. Pancreatic enzymes and Fibrosing Colonopathy. J Cyst Fibros 2015; 14:153. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25242743.\n\n26. Peckham D, Whitaker P. Reply to Professor Taylor. J Cyst Fibros 2014; 13:486–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24746986.\n\n27. Sermet-Gaudelus I, Bianchi ML, Garabédian M, Aris RM, Morton A, Hardin DS, et al. European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros 2011; 10:S16–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21658635.\n\n28. Vendrell M, de Gracia J, Olveira C, Martinez MA, Giron R, Maiz L, et al. [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]. Arch Bronconeumol 2008; 44:629–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19007570.\n\n29. Olveira C, Olveira G, Gaspar I, Dorado A, Cruz I, Soriguer F, et al. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res 2013; 22:597–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22544417.\n\n30. Olveira C, Olveira G, Dorado A. Gasto energético en sujetos adultos con Fibrosis Quística(FQ): concordancia entre la calorimetría indirecta y diferentes fórmulas estimativas. Arch Bronconeumol 2007; 43:366–72.\n\n31. Kerem E, Conway S, Elborn S, Heijerman H, Barreto C, Bilton D, et al. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005; 4:7–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15752677.\n\n32. Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur Respir J 2014; 43:125–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23598952.\n\n33. Soler JJ, Sánchez L, Román P, Martínez MA, Perpiñá M. [Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease]. Arch Bronconeumol 2004; 40:250–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15161591.\n\n34. Girón R, Matesanz C, García-Río F, de Santiago E, Mancha A, Rodríguez-Salvanés F, et al. Nutritional State during COPD Exacerbation: Clinical and Prognostic Implications. Ann Nutr Metab 2009; 54:52–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19252400.\n\n35. Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J\n---\n576     BLOQUE: PATOLOGÍAS ESPECÍFICAS\n\nCachexia Sarcopenia Muscle 2011; 2:81–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21766053.\n\n36. Budweiser S, Meyer K, Jörres RA, Heinemann F, Wild PJ, Pfeifer M. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases. Eur J Clin Nutr 2008; 62:436–43. Available from: http://www.nature.com/doifinder/10.1038/sj.ejcn.1602708.\n\n37. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44:1504–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25234804.\n\n38. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16002800.\n\n39. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}